This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Beckman Research Institute, City of Hope, Sanford-Burnham Medical Research Institute, Sanford-Burnham Medical Research Institute at Lake Nona. Active years: 2015-2016.
Company Filing History:
2 out of 692 
1 out of 99 
1 out of 1 Years Active: 2015-2016
Title: Daniela Divlianska: Innovator in Cancer Treatment
Introduction
Daniela Divlianska is a prominent inventor based in Orlando, FL (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on developing methods to inhibit SUMOylation enzymes, which play a crucial role in cancer cell proliferation.
Latest Patents
Her latest patents include "Singleton inhibitors of sumoylation enzymes and methods for their use." This invention provides a SUMOylation inhibitor compound that can be administered to cells to inhibit SUMOylation enzymes, specifically SUMO E1 or SUMO E2. The method can be utilized to target cancer cells both in vitro and in vivo. Additionally, she has developed methods for treating cancer, degenerative diseases, and viral infections using these compounds.
Another significant patent is "Inhibition of small ubiquitin-like modifier enzymes with substituted pyrrolo[2,3-b]quinoxalines." This invention outlines methods for inhibiting small ubiquitin-like modifier enzymes in cells, which can also be applied to cancer treatment. The pharmaceutical compositions developed may include small ubiquitin-like modifier inhibitor compounds, further enhancing the potential for effective cancer therapies.
Career Highlights
Throughout her career, Daniela has worked with esteemed organizations such as the Beckman Research Institute, City of Hope, and Sanford-Burnham Medical Research Institute at Lake Nona. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Yi-Jia Li and Ekaterina Bobkova. Their collaborative efforts have further advanced the research and development of innovative cancer treatments.
Conclusion
Daniela Divlianska's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her patents and research continue to pave the way for new therapeutic approaches that could significantly improve patient outcomes.